Bank of Montreal Can Boosts Position in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Bank of Montreal Can boosted its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 3.5% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 733,006 shares of the company's stock after acquiring an additional 25,053 shares during the quarter. Bank of Montreal Can owned 0.16% of GE HealthCare Technologies worth $57,306,000 at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in the business. CoreFirst Bank & Trust bought a new position in shares of GE HealthCare Technologies during the fourth quarter valued at $25,000. Runnymede Capital Advisors Inc. bought a new position in GE HealthCare Technologies during the 4th quarter valued at about $28,000. Continuum Advisory LLC boosted its holdings in shares of GE HealthCare Technologies by 101.8% during the 3rd quarter. Continuum Advisory LLC now owns 333 shares of the company's stock valued at $31,000 after acquiring an additional 168 shares during the last quarter. Bank of Jackson Hole Trust bought a new stake in shares of GE HealthCare Technologies in the fourth quarter worth approximately $32,000. Finally, OFI Invest Asset Management purchased a new position in shares of GE HealthCare Technologies during the fourth quarter valued at approximately $34,000. 82.06% of the stock is currently owned by hedge funds and other institutional investors.

GE HealthCare Technologies Stock Performance

GEHC stock traded down $1.39 during midday trading on Tuesday, reaching $63.00. The stock had a trading volume of 1,644,353 shares, compared to its average volume of 3,128,816. The company has a debt-to-equity ratio of 0.88, a quick ratio of 0.83 and a current ratio of 1.04. The firm has a fifty day simple moving average of $81.29 and a two-hundred day simple moving average of $83.80. The stock has a market cap of $28.81 billion, a PE ratio of 14.55, a P/E/G ratio of 3.19 and a beta of 1.14. GE HealthCare Technologies Inc. has a 52-week low of $57.65 and a 52-week high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last announced its quarterly earnings results on Thursday, February 13th. The company reported $1.45 earnings per share for the quarter, beating the consensus estimate of $1.26 by $0.19. The company had revenue of $5.32 billion during the quarter, compared to analysts' expectations of $5.33 billion. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. As a group, equities research analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, May 15th. Investors of record on Friday, April 25th will be issued a $0.035 dividend. The ex-dividend date is Friday, April 25th. This represents a $0.14 dividend on an annualized basis and a yield of 0.22%. GE HealthCare Technologies's payout ratio is 3.23%.

Analyst Upgrades and Downgrades

A number of equities research analysts have commented on GEHC shares. Jefferies Financial Group raised shares of GE HealthCare Technologies from a "hold" rating to a "buy" rating and lifted their target price for the stock from $95.00 to $103.00 in a research report on Wednesday, January 8th. The Goldman Sachs Group upgraded GE HealthCare Technologies from a "neutral" rating to a "buy" rating and upped their price objective for the company from $85.00 to $100.00 in a research report on Tuesday, March 11th. Wells Fargo & Company raised their target price on GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an "overweight" rating in a research report on Friday, February 14th. Finally, Citigroup upped their price target on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the company a "buy" rating in a research report on Thursday, February 13th. One research analyst has rated the stock with a sell rating, two have given a hold rating, eight have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, GE HealthCare Technologies currently has a consensus rating of "Moderate Buy" and an average price target of $97.73.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.